Aileen Chang, MD, MSPH is an Associate Professor of Medicine and Microbiology, Immunology, and Tropical Medicine at the George Washington University School of Medicine & Health Sciences in Washington, DC. She received her MD from Columbia University and her MSPH during Internal Medicine residency at the University of Miami. She is fellowship trained in General Medicine and is certified in tropical medicine (ASTMH) and rheumatology (ACR). Dr. Chang is a clinical-translational investigator focused on arboviruses, including chikungunya, dengue, and Zika. She works with Latin American cohorts to study pathogenesis and accelerate therapeutics, including leading work on the largest Latin American chikungunya arthritis cohort, IL-2–based approaches, and methotrexate clinical trials. As Chief Operating Officer of the Dengue Relief Foundation, she supported CDC and Florida Department of Health task forces during the 2009 dengue outbreak and trained clinicians in dengue management. Her current work includes mechanistic studies of dengue vascular permeability and clinical trials for dengue-induced vascular leakage including co-leading the arboviral platform therapeutics trials for the NIH STRIVE Network.
Aileen Chang, MD, MSPH is an Associate Professor of Medicine and Microbiology, Immunology, and Tropical Medicine at the George Washington University School of Medicine & Health Sciences in Washington, DC. She received her MD from Columbia University and her MSPH during Internal Medicine residency at the University of Miami. She is fellowship trained in General Medicine and is certified in tropical medicine (ASTMH) and rheumatology (ACR). Dr. Chang is a clinical-translational investigator focused on arboviruses, including chikungunya, dengue, and Zika. She works with Latin American cohorts to study pathogenesis and accelerate therapeutics, including leading work on the largest Latin American chikungunya arthritis cohort, IL-2–based approaches, and methotrexate clinical trials. As Chief Operating Officer of the Dengue Relief Foundation, she supported CDC and Florida Department of Health task forces during the 2009 dengue outbreak and trained clinicians in dengue management. Her current work includes mechanistic studies of dengue vascular permeability and clinical trials for dengue-induced vascular leakage including co-leading the arboviral platform therapeutics trials for the NIH STRIVE Network.